Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives

Published:2015-07-28 Issue:7 Volume:25 Page:953-962
ISSN:1017-7825
Container-title:Journal of Microbiology and Biotechnology
language:en
Short-container-title:Journal of Microbiology and Biotechnology

Author:

Baeshen Mohammed N.,Al-Hejin Ahmed M.,Bora Roop S.,Ahmed Mohamed M. M.,Ramadan Hassan A. I.,Saini Kulvinder S.,Baeshen Nabih A.,Redwan Elrashdy M.

Publisher

Journal of Microbiology and Biotechnology

Subject

Applied Microbiology and Biotechnology,General Medicine,Biotechnology

Cited by 239 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant protein expression in Escherichia coli;Fundamentals of Recombinant Protein Production, Purification and Characterization;2025

2. The potential of RuBisCO in CO2 capture and utilization;Progress in Energy and Combustion Science;2024-11

3. Preparation of recombinant neuritin protein;Protein Expression and Purification;2024-11

4. Classification of imbalanced datasets utilizing the synthetic minority oversampling method in conjunction with several machine learning techniques;Iran Journal of Computer Science;2024-09-11

5. Escherichia coli in the production of biopharmaceuticals;Biotechnology and Applied Biochemistry;2024-09-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP